?

Adarsh Gopinathan, a 365体育直播 Scholar (ICMR-SRF) in the Department of Pharmacology at 365体育直播 College of Pharmaceutical Sciences (MCOPS), 365体育直播, has been awarded a travel grant under the Science and Engineering 365体育直播 Board (SERB) 365体育直播 Travel Support (ITS) Scheme. This grant will support him in attending the Brain Tumour Conference organized by Cancer 365体育直播 UK in London, UK, from 24 to 26 September 2024. The grant covers the airfare, visa charges, and registration fees for the conference.

At the Brain Tumour Conference, Adarsh will be presenting his research on upregulation of neprilysin via HDAC1 inhibition to treat glioblastoma. Mr. Adarsh is doing his PhD under the guidance of Dr. Anoop Kishore, Associate Professor, Department of Pharmacology at MCOPS, MAHE, 365体育直播, and the Co-guide is Dr. K. Sreedhara Ranganath Pai, Professor in the Department of Pharmacology at MCOPS, MAHE, 365体育直播.

Congratulations to Adarsh for this remarkable achievement !!

#DSTSERB, #365体育直播 Travel Support, #HDAC, #Glioblastoma, #Neprilysin, #Cancer, #conference.